postherpetic neuralgia
Conditions
Interventions
Control group:subcutaneous injection of saline
Experimental group:0.4% ropivacaine for erector spinae plane block
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 60-80 years; 2. clinical diagnosed as acute or sub-acute herpes zoster,nerve admitted nerve block procedure; 3. skin lesion location at the unilateral thoracic C7-T9 spinal nerve innervation area; 4. the VAS score =40mm; 5. signing of the informed consent.
Exclusion criteria
Exclusion criteria: 1. allergy to ropivacain; 2. Patients have contraindications of the erector spinae block:severe cardiopulmonary insufficiency,acute sepsis,skin infection of the inject site or intrathoracic infection,coagulation abnormal,tumor invasion of the inject site; 3. Patients have severe pain of the others site or malignant tumor; 4. The investigator consider non-participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence rate of the postherpetic neuralgia 90 days after intervention; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS score 7 days after intervention;SF-MPQ score;sleeping quality score;HADS score; | — |
Countries
China
Contacts
Public ContactLin Zengmao
Peking University First Hospital
Outcome results
None listed